Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by quest13on Jun 09, 2015 11:18am
152 Views
Post# 23810928

RE:RE:RE:RE:RE:RE:RE:DILUTION OF ZENITH SHARES OF PRESENT HOLDERS???

RE:RE:RE:RE:RE:RE:RE:DILUTION OF ZENITH SHARES OF PRESENT HOLDERS???
well Phil the prince of insufficient light I must say that I have read both the zenith & Resverlogix send out to shareholders for tweeting as they were posted late yesterday. I see them as normal changes required to deal with the fact that RVX is actually going to receive payments from a third party deal for royalties from Shenzhen for activities in the territories which may be less than the revenue contemplated to be earned by an acquirer of RVX. I do not see anything that will be unduly disadvantageous to either the shareholders of Zenith or RVX. It seems to me that management is dealing appropriately with the current circumstances that they believe the companies are better off going ahead as they see rather than accepting less than they feel the company is worth and selling for what a possible purchaser of the whole company would pay right now.
Bullboard Posts